MedTrace Logo

Drug Use Investigation for ALLERMIST

NCT01376206 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2017-05-22

No results posted yet for this study

Summary

To investigate possible problems or questions in safety and efficacy of ALLERMIST Nasal Spray in Japanese subjects with allergic rhinitis under the practical use conditions

Conditions

  • Rhinitis

Interventions

DRUG

Fluticasone

Collection of safety data

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2010-09-30
Completion
2011-05-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01376206 on ClinicalTrials.gov